Skip to main content

Advertisement

SpringerLink
Log in

Cutis verticis gyrata-like skin toxicity during treatment of melanoma patients with the BRAF inhibitor vemurafenib after whole-brain radiotherapy is a consequence of the development of multiple follicular cysts and milia

  • Letter to the Editor
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Harding JJ, Barker CA, Carvajal RD et al (2014) Cutis verticis gyrata in association with vemurafenib and whole-brain radiotherapy. J Clin Oncol 32:e54–56

  2. Boussemart L, Routier E, Mateus C et al (2013) Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients. Ann Oncol 24:1691–1697

    Article  CAS  PubMed  Google Scholar 

  3. Schulze B, Meissner M, Wolter M et al (2014) Unusual acute and delayed skin reactions during and after whole-brain radiotherapy in combination with the BRAF inhibitor vemurafenib. Strahlenther Onkol 190:229–232

    Article  CAS  PubMed  Google Scholar 

  4. Rompoti N, Schilling B, Livingstone E et al (2013) Combination of BRAF inhibitors and brain radiotherapy in patients with metastatic melanoma shows minimal acute toxicity. J Clin Oncol 31:3844–3845

    Article  PubMed  Google Scholar 

Download references

Compliance with ethical guidelines

Informed consent

Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.

Conflict of interest

N. Lang, F. Sterzing, A. H. Enk, and J. C. Hassel state that there are no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Dermatology and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany

    Nina Lang,  Alexander H. Enk &  Jessica C. Hassel

  2. Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany

    Florian Sterzing

Authors
  1. Nina Lang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Florian Sterzing
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexander H. Enk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jessica C. Hassel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nina Lang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lang, N., Sterzing, F., Enk, A. et al. Cutis verticis gyrata-like skin toxicity during treatment of melanoma patients with the BRAF inhibitor vemurafenib after whole-brain radiotherapy is a consequence of the development of multiple follicular cysts and milia. Strahlenther Onkol 190, 1080–1081 (2014). https://doi.org/10.1007/s00066-014-0707-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-014-0707-0

Keywords

Search

Navigation